Effect of physical therapy on bone remodelling in preterm infants: a multicenter randomized controlled clinical trial

Galaad Torró-Ferrero1, Francisco Javier Fernández-Rego2,3, María Rosario Jiménez-Liria4

  • 1International School of Doctorate of the University of Murcia (EIDUM), University of Murcia, 30100, Murcia, Spain. galaad.torro@um.es.

BMC Pediatrics
|June 23, 2022
PubMed

Insights

Reflex locomotion therapy significantly improved bone formation in preterm infants compared to other physiotherapy methods. This therapy is a promising approach for preventing and treating osteopenia of prematurity.

Area of Science:

  • Neonatal Medicine
  • Developmental Pediatrics
  • Physical Therapy

Background:

  • Preterm infants exhibit lower bone mineralization than term infants due to reduced calcium incorporation late in gestation.
  • Osteopenia of prematurity is a significant concern in neonatal care.
  • Understanding interventions to enhance bone health in preterm neonates is crucial.

Purpose of the Study:

  • To evaluate the impact of reflex locomotion therapy on bone modeling and growth in preterm infants.
  • To compare the efficacy of reflex locomotion therapy with other physiotherapy modalities for bone health.

Main Methods:

  • A multicenter randomized controlled trial involving 106 preterm infants (26-34 weeks gestation).
  • Infants were assigned to reflex locomotion therapy (EGrlt), passive mobilizations with joint compression (EGpmc), or massage (CG) for one month.
  • Bone formation and resorption were assessed using bone biomarkers, with osteocalcin as a key indicator.

Main Results:

  • The study included 38 infants in the EGrlt group, 32 in the EGpmc group, and 36 in the CG group.
  • All groups were comparable in gender, gestational age, and birth weight.
  • Significant improvements in bone formation, measured by osteocalcin levels, were observed in the EGrlt group compared to the other groups (p=0.013).

Conclusions:

  • Reflex locomotion therapy demonstrated superior effectiveness in enhancing bone formation among preterm infants.
  • This therapy presents a valuable option for the prevention and management of osteopenia of prematurity.
  • Further research may explore long-term bone health outcomes associated with this intervention.
Abstract